Anti-cancer antibodies are often used as a chemotherapeutic agent. They act by binding cell surface receptors, like Epidermal Growth Factor Receptor, whose aberrant activation leads to increase cellular proliferation. How are these antibodies affecting the protein interactions at the cell surface of these cancer cells?
